TCR Gene Therapy in Pancreatic Cancer | NEJM
5 مناظر
• 07/13/23
0
0
ایمبیڈ
administrator
سبسکرائبرز
Pancreatic cancer is resistant to most forms of therapy but may be vulnerable to T cells that recognize a “hot-spot” mutation — KRAS G12D — commonly found in that cancer. New research findings are summarized in a short video.
To see the full article, follow this link: https://nej.md/3wS9STm
مزید دکھائیں
فیس بک کے تبصرے
SORT BY-
سرفہرست تبصرے
-
تازہ ترین تبصرے